TRIM33 and neoplasm: Many myositis‐specific autoantibodies (MSA), such as anti‐TIF1γ, were detected in large cohort studies as the origin of carcinogenesis, which can lead us to elevate the clinical suspicion of neoplasia and advocate screening of these patients.18, 19